Global Veterinary Antibiotics Market

Report ID : 1128 | Published : 2021-07-26 | Pages: 140 | Format:

Antibiotics can be used to treat a single animal with clinical disease or a large group of animals. In many countries, antibiotics are commonly added to commercial feed for growth promotion in chickens. Antibiotics have effectively improved the rate and efficiency of gain in swine, cattle, and poultry. The different applications of antibiotics in food animals have been described as therapeutic use, prophylactic use, and subtherapeutic use. The global Veterinary antibiotics market is driven by end-use verticals consisting of dairy, meat industry applications. The increasing consumer preference for various dairy products and the rise in companion animal ownership is expected to increase the demand. Increasing animal disease outbreaks and increasing initiatives concerning animal health and welfare is anticipated to further strengthen its demand over the forecast period.

The Global Veterinary Antibiotics market is categorized on the basis of product, End-Users, and region. On the basis of Product Type, the market is segmented into Anti-parasitic, Anti-Bacterial, Non-steroidal anti-inflammatory drug, and Others. On the basis of End-users Mode Type, the market is segmented into Dairy Farm, Poultry Farm, and Others. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.

The report further identifies detailed competitive intelligence of Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Virbac, Zoetis, Inc., Inovet Group, Dopharma, and Other Prominent Players.

Key Factors Covered in Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Veterinary Antibiotics Market Snapshot

Chapter 4. Global Veterinary Antibiotics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis of Key Veterinary Companies

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Major Investment, Partnerships and Collaborations in Veterinary Research

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2020 & 2028

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Product Type:

5.2.1. Anti-parasitic

5.2.2. Anti-Bacterial

5.2.3. Non-steroidal anti-inflammatory drug

5.2.4. Others

Chapter 6. Market Segmentation 2: End-Users Estimates & Trend Analysis

6.1. End-Users & Market Share, 2020 & 2028

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:

6.2.1. Dairy Farm

6.2.2. Poultry Farm

6.2.3. Others

Chapter 7. Veterinary Antibiotics Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Veterinary Antibiotics Market revenue (US$ Million) estimates and forecasts by Product Type, 2020-2028

7.1.2. North America Veterinary Antibiotics Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028

7.1.3. North America Veterinary Antibiotics Market revenue (US$ Million) estimates and forecasts by country, 2020-2028

7.2. Europe

7.2.1. Europe Veterinary Antibiotics Market revenue (US$ Million) by Product Type, 2020-2028

7.2.2. Europe Veterinary Antibiotics Market revenue (US$ Million) by End-Users, 2020-2028

7.2.3. Europe Veterinary Antibiotics Market revenue (US$ Million) by country, 2020-2028

7.3. Asia Pacific

7.3.1. Asia Pacific Veterinary Antibiotics Market revenue (US$ Million) by Product Type, 2020-2028

7.3.2. Asia Pacific Veterinary Antibiotics Market revenue (US$ Million) by End-Users, 2020-2028

7.3.3. Asia Pacific Veterinary Antibiotics Market revenue (US$ Million) by country, 2020-2028

7.4. Latin America

7.4.1. Latin America Veterinary Antibiotics Market revenue (US$ Million) by Product Type, (US$ Million)

7.4.2. Latin America Veterinary Antibiotics Market revenue (US$ Million) by End-Users, 2020-2028

7.4.3. Latin America Veterinary Antibiotics Market revenue (US$ Million) by country, (US$ Million) 2020-2028

7.5. Middle East & Africa

7.5.1. Middle East & Africa Veterinary Antibiotics Market revenue (US$ Million) by Product Type, (US$ Million)

7.5.2. Middle East & Africa Veterinary Antibiotics Market revenue (US$ Million) by End-Users, (US$ Million)

7.5.3. Middle East & Africa Veterinary Antibiotics Market revenue (US$ Million) by country, (US$ Million) 2020-2028

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Bayer AG

8.2.2. Boehringer Ingelheim GmbH

8.2.3. Ceva Sante Animale S.A.

8.2.4. Crystal Pharma

8.2.5. Dechra Pharmaceuticals PLC

8.2.6. Huvepharma AD

8.2.7. Eli Lilly Company

8.2.8. Elanco

8.2.9. Merck & Co., Inc.

8.2.10. Sanofi S.A.

8.2.11. Vetoquinol S.A.

8.2.12. Virbac

8.2.13. Zoetis, Inc.

8.2.14. Inovet Group

8.2.15. Dopharma

8.2.16. Other Prominent Players

Global Veterinary Antibiotics Market Segmentation:

Global Veterinary Antibiotics Market by Product Type

  • Anti-parasitic
  • Anti-Bacterial
  • Non-steroidal anti-inflammatory drug
  • Others

Global Veterinary Antibiotics Market by End-Users Mode

  • Dairy Farm
  • Poultry Farm
  • Others

Global Veterinary Antibiotics Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients